Mai Capital Management Athersys, Inc Transaction History

Mai Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$0.18 - $0.86 $299,965 - $1.43 Million	1,666,477 Added 1061.54%	1,823,463 $474,000
Q2 2020 Jul 27, 2020	SELL	$1.97 - $3.98 $36,642 - $74,028	-18,600 Reduced 10.59%	156,986 $433,000
Q1 2020 Apr 16, 2020	BUY	$1.17 - $3.0 $21,762 - $55,800	18,600 Added 11.85%	175,586 $527,000
Q4 2019 Feb 03, 2020	BUY	$1.16 - $1.42 $182,103 - $222,920	156,986 New	156,986 $193,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.